Immunic, Inc.
IMUX
$0.65
$0.00-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.34% | -6.85% | 1.56% | -7.37% | 24.60% |
| Total Depreciation and Amortization | 31.97% | 42.98% | 43.81% | 20.72% | 14.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.40% | -43.89% | -48.00% | 101.94% | -64.54% |
| Change in Net Operating Assets | -42.34% | -59.32% | -22.45% | -98.61% | -58.40% |
| Cash from Operations | -18.01% | -24.60% | -9.68% | -19.68% | -5.46% |
| Capital Expenditure | 64.08% | 67.62% | -7.28% | 20.96% | -153.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 64.08% | 67.62% | -106.84% | -102.79% | -42,500.00% |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,151.70% | 5,991.09% | -92.92% | -73.48% | -98.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.62% | -12.95% | -99.90% | 7,115.97% | 32.93% |
| Foreign Exchange rate Adjustments | -81.23% | 265.36% | -179.18% | -297.33% | -75.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,773.62% | -1,114.48% | -1,923.95% | 81.68% | 95.28% |